Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImpax Asset Management Regulatory News (IPX)

Share Price Information for Impax Asset Management (IPX)

Share Price is delayed by 15 minutes
Get Live Data
95.20    2.30 (2.48%)
Bid:
94.10
Ask:
95.30
Spread: 1.20 (1.275%)
Market Cap: £115.67m
IPX Live PriceLast checked at - London Stock Exchange

Intraday Impax Asset Management Share Chart

Q2 AUM update

8 Apr 2025 07:00

RNS Number : 0001E
Impax Asset Management Group plc
08 April 2025
 

Impax Asset Management Group plc

("Impax" or the "Company")

Q2 AUM update

Impax, the AIM-listed specialist investor focused on the transition to a more sustainable economy, today provides an update on the development of its assets under discretionary and advisory management ("AUM") for the first quarter of its financial year.

On 31 March 2025, the Company's AUM totalled £25.3 billion, representing a decrease of 25.7% over the three-month period.

Ian Simm, Chief Executive, said:

"Since the start of the calendar year, relative to generic indices, our investment strategies have benefitted from the broadening of market performance away from the US-listed mega-cap stocks that had previously dominated global equity returns. Nevertheless, as we previously signalled ahead of our AGM on 5 March, we experienced a challenging quarter in terms of net flows, with the winding-up of the £5.1 billion St. James's Place Sustainable & Responsible Equity Fund mandate and a small number of account closures within our institutional channel exacerbating the impact of negative market returns."

"Market conditions in the second half of FY25 remain highly uncertain. Given the fall in our AUM and the impact on global markets of an escalating trade war, we anticipate that full year profits will be below market expectations."

"We were pleased to announce last week the closing of our acquisition of the European assets of SKY Harbor Capital Management. This has given us additional investment management capability in fixed income as well as £1.1 billion of assets under management, which will be reflected in our next AUM update, which is due in July."

Figure 1. Movements in the Company's AUM for the quarter ended 31 March 2025

Listed equities

Fixed

income

Private

Markets

Total firm

£m

£m

£m

£m

Total AUM at

31 December 2024

 

 

32,019

1,488

601

34,108

Net flows

(7,724)

(62)

-

(7,786)

Performance, market movement, and FX

(992)

(4)

7

(990)

Total AUM at

31 March 2025

23,302

1,422

609

25,332

 

 

This announcement contains information that would be designated as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 ("MAR"), and is disclosed in this announcement in accordance with the Company's obligations under Article 17 of MAR.

 

LEI number: 213800AJDNW4S2B7E680

- Ends -

 

Enquiries:

 

Impax Asset Management Group plc

Ian Simm, Chief Executive

+44 (0)20 3912 3000

Paul French, Head of Corporate Communications

p.french@impaxam.com

+44 (0)20 3912 3032

Montfort Communications

Gay Collins

+44(0)77 9862 6282

Jack Roddan

impax@montfort.london

+44(0)78 2567 0695

Peel Hunt LLP, Nominated Adviser and Joint Broker

Andrew Buchanan

Dan Webster

Oliver Jackson

+44 (0)20 7418 8900

Berenberg, Joint Broker

James Felix

+44 (0)203 207 7800

John Welch

Dan Gee-Summons

 

About Impax Asset Management

 

Founded in 1998, Impax is a specialist asset manager, with approximately £25.3 billion of assets under management as of 31 March 2025 in both listed and private markets strategies, investing in the transition to a more sustainable global economy.

Impax believes that capital markets will be shaped profoundly by global sustainability challenges, including climate change, pollution and essential investments in human capital, infrastructure and resource efficiency. These trends will drive growth for well-positioned companies and create risks for those unable or unwilling to adapt.

The company seeks to invest in higher quality companies with strong business models that demonstrate sound management of risk. Impax offers a well-rounded suite of investment solutions spanning multiple asset classes seeking superior risk-adjusted returns over the medium to long term.

www.impaxam.com

Issued in the UK by Impax Asset Management Group plc, whose shares are quoted on the Alternative Investment Market of the London Stock Exchange.  Impax Asset Management Group plc is registered in England & Wales, number 03262305.  AUM relates to Impax Asset Management Limited, Impax Asset Management (AIFM) Limited, Impax Asset Management Ireland Limited and Impax Asset Management LLC. Impax Asset Management Limited and Impax Asset Management (AIFM) Limited are authorised and regulated by the Financial Conduct Authority and are wholly owned subsidiaries of Impax Asset Management Group plc. Please note that the information provided on www.impaxam.com and links from it should not be relied upon for investment purposes. 

 

Impax is trademark of Impax Asset Management Group Plc. Impax is a registered trademark in the UK, EU, US, Hong Kong, Canada, Japan and Australia. © Impax Asset Management LLC, Impax Asset Management Limited and/or Impax Asset Management (Ireland) Limited. All rights reserved.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTIRMFTMTAMBTA
Date   Source Headline
2nd Jun 20236:01 pmRNSDirector/PDMR Shareholding
31st May 20237:00 amRNSHalf-year Report
26th May 20233:10 pmRNSInvestment Advisory Agreement
26th May 20237:00 amRNSHolding(s) in Company
23rd May 20237:00 amRNSInvestor Presentation of Interim Results
15th May 20232:25 pmRNSHolding(s) in Company
9th May 20237:00 amRNSNotice of Results
11th Apr 20237:00 amRNSQ2 AUM Update
16th Mar 20231:57 pmRNSDirectorate Changes
16th Mar 20231:56 pmRNSResult of AGM
15th Mar 20238:43 amRNSHolding(s) in Company
9th Jan 20237:00 amRNSQ1 AUM update
20th Dec 20223:46 pmRNSDirector/PDMR Shareholding
20th Dec 20223:33 pmRNSHolding(s) in Company
16th Dec 20224:46 pmRNSNotice of AGM
13th Dec 20223:02 pmRNSHolding(s) in Company
1st Dec 20225:06 pmRNSPublication of Annual Financial Report
1st Dec 20227:00 amRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSFinal Results
25th Nov 20227:00 amRNSinvestor Presentation of Full Year Results
23rd Nov 20227:00 amRNSNotice of results
21st Nov 20225:05 pmRNSHolding(s) in Company
7th Oct 20227:00 amRNSAUM update
3rd Oct 20228:22 amRNSHolding(s) in Company
13th Sep 202210:49 amRNSHolding(s) in Company
9th Sep 20221:32 pmRNSHolding(s) in Company
2nd Sep 20223:34 pmRNSHolding(s) in Company
12th Aug 20229:37 amRNSDirector/PDMR Shareholding
21st Jul 20225:38 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSAUM update
6th Jul 20221:50 pmRNSDirector/PDMR and PCA Shareholding
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSBoard Appointment
16th Jun 20224:37 pmRNSDirector/PDMR and PCA Shareholding
14th Jun 20227:00 amRNSHolding(s) in Company
7th Jun 20224:36 pmRNSHolding(s) in Company
1st Jun 20227:00 amRNSInterim results to 31 March 2022
12th May 20228:16 amRNSHolding(s) in Company
12th May 20227:00 amRNSInvestor Presentation of Interim Results
6th May 20227:00 amRNSDate of Interim Results
26th Apr 20223:37 pmRNSHolding(s) in Company
20th Apr 20222:11 pmRNSDirector/PDMR Shareholding
7th Apr 20227:00 amRNSAUM update
30th Mar 20222:14 pmRNSDirector/PDMR Shareholding
29th Mar 20226:10 pmRNSResult of AGM
4th Mar 20222:30 pmRNSDirector/PDMR and PCA Shareholding
25th Feb 20227:00 amRNSAIM Rule 17 Schedule Two (g) Update
14th Feb 20221:24 pmRNSDistribution agreement
10th Jan 20227:00 amRNSAUM update
20th Dec 20216:04 pmRNSNotice of Annual General Meeting ("AGM")

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.